These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 2750638

  • 1. Theophylline in serum and in bronchoalveolar lavage (BAL) in atopic bronchial asthma and chronic bronchitis.
    Plusa T, Józefczak E, Raczka A.
    Allergol Immunopathol (Madr); 1989; 17(1):29-32. PubMed ID: 2750638
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunobiochemical evaluation of bronchoalveolar lavage (BAL) in atopic bronchial asthma, chronic bronchitis and bronchiectasis.
    Plusa T, Wäsek Z.
    Allergol Immunopathol (Madr); 1987; 15(4):209-13. PubMed ID: 3318350
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of slow-release theophylline on airway inflammation in bronchial asthma].
    Adachi M, Minoguchi K, Mita S, Kokubu F, Suzuki H, Sano Y, Akiyama K, Yasuhara H.
    Arerugi; 1998 Aug; 47(8):734-43. PubMed ID: 9796114
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG, Miller E, Janky DG, Decouto J, Edelman L.
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function.
    van der Vet AP, Kreukniet J, Drost RH, Maes RA.
    Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):339-44. PubMed ID: 4030161
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
    González MA, Kisicki J, Straughn AB.
    Clin Ther; 1994 Jul; 16(4):686-92. PubMed ID: 7982257
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Monitoring of theophylline treatment by saliva and plasma concentrations.
    Juntunen-Backman K, Backman A, Björkstén F, Finnilä MJ.
    Allergol Immunopathol (Madr); 1988 Jul; 16(1):5-9. PubMed ID: 3381714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.